Back
Intra-Cellular Therapies Stock Price Chart
Sponsored
ITCI
Sponsored
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]
Buy
61
ITCI
Intra-Cellular Therapies
Last Price:
$126.47
Seasonality Move:
2.93%
7 Day Trial
ALL ACCESS PASS
$
7
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.
Intra-Cellular Therapies Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 111.74 | Buy |
20-day SMA: | 95.26 | Buy |
50-day SMA: | 89.75 | Buy |
200-day SMA: | 77.18 | Buy |
8-day EMA: | 114.96 | Buy |
20-day EMA: | 101.39 | Buy |
50-day EMA: | 91.52 | Buy |
200-day EMA: | 79.08 | Buy |
Intra-Cellular Therapies Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 10.51 | Buy |
Relative Strength Index (14 RSI): | 85.88 | Buy |
Chaikin Money Flow: | -5179263 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (76.16 - 110.04) | Buy |
Bollinger Bands (100): | (70.86 - 94.24) | Buy |
Intra-Cellular Therapies Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Intra-Cellular Therapies Stock
Is Intra-Cellular Therapies Stock a Buy?
-
Intra-Cellular Therapies share price is 126.20 while ITCI 8-day simple moving average is 111.74, which is a Buy signal.
-
The stock price of ITCI is 126.20 while Intra-Cellular Therapies 20-day SMA is 95.26, which makes it a Buy.
-
Intra-Cellular Therapies 50-day simple moving average is 89.75 while ITCI share price is 126.20, making it a Buy technically.
-
ITCI stock price is 126.20 and Intra-Cellular Therapies 200-day simple moving average is 77.18, creating a Buy signal.
ITCI Technical Analysis vs Fundamental Analysis
Buy
61
Intra-Cellular Therapies (ITCI)
is a Buy
Is Intra-Cellular Therapies a Buy or a Sell?
-
Intra-Cellular Therapies stock is rated a BuyThe current Intra-Cellular Therapies [ITCI] share price is $126.20. The Score for ITCI is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Intra-Cellular Therapies Stock Info
Market Cap:
13.4B
Price in USD:
126.20
Share Volume:
6M
Intra-Cellular Therapies 52-Week Range
52-Week High:
128.00
52-Week Low:
62.78
Buy
61
Intra-Cellular Therapies (ITCI)
is a Buy
Intra-Cellular Therapies Share Price Forecast
-
What is the Intra-Cellular Therapies stock price today?The Intra-Cellular Therapies stock price is 126.20 USD today.
-
Will ITCI stock go up or go down?Intra-Cellular Therapies> share price is forecast to RISE/FALL based on technical indicators
-
Is Intra-Cellular Therapies overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intra-Cellular Therapies is not overvalued.
Is Intra-Cellular Therapies Stock a Buy?
-
Intra-Cellular Therapies share price is 126.20 while ITCI 8-day exponential moving average is 114.96, which is a Buy signal.
-
The stock price of ITCI is 126.20 while Intra-Cellular Therapies 20-day EMA is 101.39, which makes it a Buy.
-
Intra-Cellular Therapies 50-day exponential moving average is 91.52 while ITCI share price is 126.20, making it a Buy technically.
-
ITCI stock price is 126.20 and Intra-Cellular Therapies 200-day simple moving average is 79.08, creating a Buy signal.
Fundamental Analysis of Intra-Cellular Therapies
Is Intra-Cellular Therapies a good investment?
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and an increase next year of $3.13 per share.
Technical Analysis of Intra-Cellular Therapies
Should I short Intra-Cellular Therapies stock?
-
ITCI Moving Average Covergence Divergence (MACD) indicator is 10.51, suggesting Intra-Cellular Therapies is a Buy
-
Intra-Cellular Therapies Relative Strength Index (RSI) is 85.88, which suggest Intra-Cellular Therapies is overbought
-
The Bollinger Bands (25) for Intra-Cellular Therapies is (76.16 - 110.04), which suggest Intra-Cellular Therapies is a Buy
-
The Bollinger Bands (100) for Intra-Cellular Therapies is (70.86 - 94.24), which suggest Intra-Cellular Therapies is a Buy
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.